Andrew Webb
Vermögen: 944 329 $ am 30.06.2026
Vermögen: 944 329 $ am 30.06.2026
Mr. Andrew J.
Webb is an Executive Chairman & Chief Executive Officer at CRISM Therapeutics Corp.
and a Chief Executive Officer & Director at Extruded Pharmaceuticals Ltd. He is on the Board of Directors at Novel Technologies Holdings Ltd. and Extruded Pharmaceuticals Ltd. Mr. Webb was previously employed as a Commercial Director by DxS Ltd., a Non-Executive Director by Arcis Biotechnology Ltd., and a Chief Executive Officer by EKF Molecular Diagnostics Ltd. He also served on the board at Convert2Green Ltd.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
9,22 % | 31.12.2025 | 7 297 190 ( 9,22 % ) | 944 329 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Novel Technologies Holdings Ltd.
Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | 23.11.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
DxS Ltd.
DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products | Corporate Officer/Principal | - |
EKF Molecular Diagnostics Ltd. | Vorstandsvorsitzender | - |
Arcis Biotechnology Ltd.
Arcis Biotechnology Ltd. BiotechnologyHealth Technology Develops and researches surface protection technology | Direktor/Vorstandsmitglied | - |
Convert2Green Ltd.
Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Provides renewable fuel solution | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
DxS Ltd.
DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products | Health Technology |
Convert2Green Ltd.
Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Provides renewable fuel solution | Process Industries |
Arcis Biotechnology Ltd.
Arcis Biotechnology Ltd. BiotechnologyHealth Technology Develops and researches surface protection technology | Health Technology |
EKF Molecular Diagnostics Ltd. | |
Novel Technologies Holdings Ltd.
Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen